DrugDashboards

Pantoprazole Sodium

Pantoprazole Sodium · PANTOPRAZOLE SODIUM 40 mg/1 · Injection, Powder, Lyophilized, For Solution · Intravenous · Cardinal Health 107, LLC

NDC 55154-7477-05 · 5 VIAL in 1 BAG / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL · NDA · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble. Historically, drugs in this position went on to a new shortage within 90 days about 0.7% of the time — roughly 4× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.7%chance of a new FDA shortage posting for pantoprazole sodium (injectable) in the next 90 days

sterile injectable · price up 28% YoY · OAI inspection at a producing facility (24 months)

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $12.94 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA209463
TE code
AP
Approval date
Jun 30, 2017
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Pantoprazole Sodium (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
Hikma Pharmaceuticals USA Inc.PANTOPRAZOLE SODIUM 40 mg/1Jul 15, 2026Sep 3, 2026
Cardinal Health 107, LLCPANTOPRAZOLE SODIUM 40 mg/1Jul 15, 2026Sep 2, 2026
Civica, Inc.PANTOPRAZOLE SODIUM 40 mg/1Jul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCPANTOPRAZOLE SODIUM 40 mg/10mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedPANTOPRAZOLE SODIUM 40 mg/10mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsPANTOPRAZOLE SODIUM 40 mg/10mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries LimitedPANTOPRAZOLE SODIUM 40 mg/10mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.PANTOPRAZOLE SODIUM 40 mg/10mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Pantoprazole Sodium — NDC 55154-7477-05," retrieved September 3, 2026, https://drugdashboards.com/drug/55154747705.

Free to cite with attribution — see how the data is put together.